4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-087435
President and CEO sold 86,706 shares at an average $9.12 ($790,923)
- President and CEO acquired 86,706 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2024-07-25 | Option exercise 10b5-1 | +50,000 | $5.04 | $252,000 | 816,130 | D |
| Patel Sanjiv President and CEO | 2024-07-25 | Sale 10b5-1 | −50,000 | $9.16 | $458,000 | 766,130 | D |
| Patel Sanjiv President and CEO | 2024-07-26 | Option exercise 10b5-1 | +36,706 | $5.04 | $184,998 | 802,836 | D |
| Patel Sanjiv President and CEO | 2024-07-26 | Sale 10b5-1 | −36,706 | $9.07 | $332,923 | 766,130 | D |
| Derivatives | |||||||
| Patel Sanjiv President and CEO | 2024-07-25 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 518,779 | D | ||
| Patel Sanjiv President and CEO | 2024-07-26 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −36,706 | 482,073 | D | ||
| Open-market sales · 86,706 sh · avg $9.12 · $790,923 | |||||||
Loading xslF345X05/ownership.xml…